# A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

> **NCT06486051** · PHASE2 · RECRUITING · sponsor: **Malaghan Institute of Medical Research** · enrollment: 60 (estimated)

## Conditions studied

- Large B-cell Lymphoma
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- Transformed Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** WZTL-002 CAR T-cells

## Key facts

- **NCT ID:** NCT06486051
- **Lead sponsor:** Malaghan Institute of Medical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-12
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486051, "A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06486051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*